Pharma Equity Group A/S (OCSE:PEG) Change In Receivables : kr0.35 Mil (TTM As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S Change In Receivables?

Pharma Equity Group A/S's change in receivables for the quarter that ended in Mar. 2024 was kr1.67 Mil. It means Pharma Equity Group A/S's Accounts Receivable declined by kr1.67 Mil from Dec. 2023 to Mar. 2024 .

Pharma Equity Group A/S's change in receivables for the fiscal year that ended in Dec. 2023 was kr-1.36 Mil. It means Pharma Equity Group A/S's Accounts Receivable increased by kr1.36 Mil from Dec. 2022 to Dec. 2023 .

Pharma Equity Group A/S's Accounts Receivable for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Pharma Equity Group A/S's liquidation value for the three months ended in Mar. 2024 was kr-44.32 Mil.

Pharma Equity Group A/S Change In Receivables Historical Data

The historical data trend for Pharma Equity Group A/S's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Change In Receivables Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-1.36

Pharma Equity Group A/S Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-0.04	-1.21	1.59	-1.70	1.67

Pharma Equity Group A/S Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.35 Mil.

Pharma Equity Group A/S (OCSE:PEG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Pharma Equity Group A/S's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Pharma Equity Group A/S's accounts receivable are only considered to be worth 75% of book value:

Pharma Equity Group A/S's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2.199	-	46.521	+	0.75 * 0	+	0.5 * 0
=	-44.32

Pharma Equity Group A/S Change In Receivables Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (OCSE:PEG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.